PCI Biotech Holding
1,8 NOK -3,12 %Vær den første som følger denne virksomhed
PCI Biotech Holding is a biopharmaceutical group, where most of the operations are conducted within the subsidiary PCI Biotech. The Group currently conducts operations in the development of therapeutic products based on the proprietary PCI technology. The solutions are intended for use in the treatment of cancer patients. PCI Biotech was originally founded in 2000 as a subsidiary of Photocure and is headquartered in Oslo.
Omsætning
4,75 mio.
EBIT %
-1.188,42 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
PCIB
Daglig lav / høj pris
1,8 / 1,89
NOK
Markedsværdi
67,19 mio. NOK
Aktieomsætning
38,21 t NOK
Volumen
21 t
Finanskalender
Delårsrapport
31.08.2023
Delårsrapport
22.11.2023
Viser Alle indholdstyper